BioCentury
ARTICLE | Company News

Eli Lilly, Novartis sales and marketing update

July 11, 2016 7:00 AM UTC

Harvard Pilgrim Health Care Inc. (Boston, Mass.) will reimburse Lilly’s Trulicity dulaglutide to treat diabetes. The amount hinges on how well the drug lowers HbA1c relative to others in its class. ...